Spire Healthcare Group (LON:SPI) Reaches New 1-Year High – Here’s What Happened

Spire Healthcare Group plc (LON:SPI – Get Free Report)’s stock price reached a new 52-week high on Monday. The stock traded as high as GBX 249.50 and last traded at GBX 248.50, with a volume of 1,619,336 shares. The stock had previously closed at GBX 249.

Analyst Upgrades and Downgrades

Separately, Royal Bank Of Canada cut Spire Healthcare Group to a “sector perform” rating and dropped their price objective for the company from GBX 300 to GBX 250 in a report on Monday, September 7th. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 247.50.

Check Out Our Latest Research Report on SPI

Spire Healthcare Group Price Performance

The company has a debt-to-equity ratio of 180.14, a quick ratio of 0.73 and a current ratio of 0.58. The stock has a market cap of £993.48 million, a PE ratio of -496.00, a P/E/G ratio of 1.06 and a beta of 0.93. The business has a 50 day moving average price of GBX 244.51 and a two-hundred day moving average price of GBX 209.46.

Spire Healthcare Group (LON:SPI – Get Free Report) last released its quarterly earnings data on Wednesday, September 30th. The company reported GBX (0.50) earnings per share for the quarter. Spire Healthcare Group had a negative net margin of 0.12% and a negative return on equity of 0.26%. Research analysts expect that Spire Healthcare Group plc will post 15.66 earnings per share for the current fiscal year.

About Spire Healthcare Group

(Get Free Report)

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.

Featured Stories

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.